Clover Health Files Form 4 Insider Trading Disclosure

Clover Health Investments Corp filed a Form 4 with the Securities and Exchange Commission on July 1, 2026, according to Investing.com. Form 4 filings disclose insider trading activity, including purchases, sales, and option exercises by company officers, directors, and significant shareholders, and are required within two business days of the transaction.

Key Takeaways
Clover Health Investments Corp filed a Form 4 on July 1, 2026, as reported by Investing.com
Form 4 filings disclose insider trading activity and are required within two business days of a transaction
The source does not provide transaction details, insider names, share counts, or transaction prices
Full disclosure details are typically available on the SEC's EDGAR database

The source confirms the filing date but does not provide transaction details, including the identity of the insider, the type of transaction, the number of shares involved, the transaction price, or the resulting ownership stake. Form 4 filings are publicly available on the SEC's EDGAR database and typically include these details. For readers following broader market updates , insider trading disclosures are part of the regulatory framework that provides transparency into corporate insider activity, though individual filings should be interpreted in the context of broader trading patterns and company performance.

Read original source